# Bio Essence Corporation (BIOE)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BIOE/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 1.30M | $ 475.5K | $ -352.3K | $ 1.57M | $ 2.34M |
| 2025 | $ 1.94M | $ 917.6K | $ 1.61M | $ 1.56M | $ -2.07M |
| 2024 | $ 340.5K | $ -1.68M | $ 655.7K | $ 2.70M | $ -2.97M |
| 2023 | $ 596.3K | $ -1.05M | $ -1.11M | $ 3.48M | $ -1.66M |
| 2022 | $ 1.10M | $ -904.5K | $ -855.6K | $ 4.66M | $ -3.24M |
| 2021 | $ 1.06M | $ -769.7K | $ -1.68M | $ 3.95M | $ -2.43M |
| 2020 | $ 1.22M | $ -759.1K | $ -942.8K | $ 2.96M | $ -1.78M |
| 2019 | $ 1.07M | $ -2.20M | $ -1.19M | $ 2.27M | $ -1.09M |
| 2018 | $ 1.30M | $ -1.93M | $ -1.23M | $ 106.4K | $ 169.4K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.67 |
| Liabilities / Eq | 0.71 |
| Current Ratio | 0.38 |

## Other views

- [Metrics](https://sponda.capital/en/BIOE.md)
- [Charts](https://sponda.capital/en/BIOE/charts.md)
- [Compare](https://sponda.capital/en/BIOE/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.